Akalazyanın epidemiyolojik özellikleri ve tedavi sonuçları: üçüncü basamak reflü-motilite merkezinde retrospektif bir çalışma

Year 2026, Volume: 9 Issue: 2, 337 - 343, 12.03.2026

Ayça Eroğlu Haktanır , Altay Çelebi

https://doi.org/10.32322/jhsm.1834533

https://izlik.org/JA77EE38WH

Abstract

Giriş ve Amaç: Akalazya, alt özofagus sfinkterinde gevşeme bozukluğu ve peristaltizmin yokluğu ile karakterize nadir bir özofagus motilite bozukluğudur. Klinik olarak ilerleyici disfaji, regürjitasyon ve kilo kaybı ile seyreder. Tanıda altın standart yüksek çözünürlüklü özofagus manometrisidir (HREM). Tedavi seçenekleri arasında pnömatik balon dilatasyonu (PBD), laparoskopik Heller miyotomi (LHM) ve peroral endoskopik miyotomi (POEM) yer alır. Tanı gecikmesi önemli bir sorundur ve hastalık progresyonunu ve tedavi sonuçlarını etkileyebilir. Bu çalışmada akalazya hastalarının demografik ve klinik özellikleri, tanı gecikmesi, alt tip dağılımı ve tedavi sonuçlarının değerlendirilmesi amaçlanmıştır.
Gereç ve Yöntem: Bu retrospektif çalışmaya bir üçüncü basamak merkezde akalazya tanısı alan 111 hasta dahil edilmiştir. Hastalar Chicago sınıflaması v4.0’a göre Tip I, II veya III olarak sınıflandırılmıştır. Demografik veriler, klinik bulgular, tanı süreleri ve tedavi yanıtları analiz edilmiştir.
Bulgular: Hastaların %55’i kadın, %45’i erkekti. Tip II akalazya en sık görülen alt tipti (%73,9). Medyan tanı gecikmesi 49,8 ay olup alt tipler arasında anlamlı fark saptanmadı. Tüm hastalarda katı gıda disfajisi, %95,5’inde sıvı disfajisi vardı. Başlangıç medyan Eckardt Skoru 7 idi (6–9). Tedavi sonrası skor tüm alt tiplerde anlamlı şekilde azaldı (p < 0,001). İlk tedaviler PBD (%38,7), POEM (%27,9) ve LHM (%11,7) idi.
Sonuç: Tanıda anlamlı gecikmelere rağmen tüm akalazya alt tiplerinde tedavi sonrası klinik sonuçlar olumluydu. Tanı gecikmesini azaltmak ve hasta sonuçlarını iyileştirmek için erken farkındalığın artırılması, HREM kullanımının yaygınlaştırılması ve hastaların zamanında uzman merkezlere yönlendirilmesi büyük önem taşımaktadır.

Keywords

Akalazya , pnömatik balon dilatasyonu , Heller miyotomi , POEM , yüksek çözünürlüklü manometri

Ethical Statement

Çalışma, Kocaeli Üniversitesi Girişimsel Olmayan Klinik Araştırmalar Etik Kurulu tarafından onaylanmıştır (Karar No: GOKAEK-2025/04/09, Proje No: 2025/72). Araştırma, Helsinki Bildirgesi’nin ilkelerine uygun olarak yürütülmüştür.

Supporting Institution

Herhangi bir kurum tarafınca desteklenmemiştir

Epidemiological characteristics and treatment outcomes of achalasia: a retrospective study from a tertiary reflux-motility center

https://izlik.org/JA77EE38WH

Abstract

Aims: Achalasia is a rare esophageal motility disorder characterized by impaired lower esophageal sphincter relaxation and the absence of peristalsis, leading to progressive dysphagia, regurgitation, and weight loss. High-resolution esophageal manometry (HREM) is the gold standard for diagnosis. Management options include pneumatic balloon dilatation (PBD), laparoscopic Heller myotomy (LHM), and peroral endoscopic myotomy (POEM). Delayed diagnosis remains a major clinical issue and may influence disease progression and treatment outcomes. This study aimed to evaluate the demographic and clinical characteristics, diagnostic delay, subtype distribution, and treatment outcomes in patients with achalasia.
Methods: This retrospective study included 111 patients diagnosed with achalasia at a tertiary care center. Patients were classified into type I, II, or III according to the Chicago classification v4.0. Demographic data, clinical presentation, diagnostic intervals, and treatment responses were analyzed.
Results: The cohort consisted of 55% female and 45% male patients. Type II was the most common subtype (73.9%). The median diagnostic delay was 49.8 months, with no significant difference between subtypes. All patients reported solid food dysphagia, and 95.5% also experienced liquid dysphagia. The median baseline Eckardt score (ES) was 7 (6–9). Post-treatment ES significantly decreased across all subtypes (p<0.001). Initial treatments included PBD (38.7%), POEM (27.9%), and LHM (11.7%).
Conclusion: Although diagnostic delays were substantial, all subtypes showed favorable post-treatment outcomes. Earlier disease recognition, increased HREM utilization, and timely referral to specialized centers are essential to reduce delays and improve clinical outcomes in achalasia.

Keywords

Achalasia , pneumatic balloon dilatation , Heller myotomy , POEM , high-resolution manometry

Ethical Statement

The study was approved by Kocaeli University, noninterventional clinical research ethical committee (Decision No: GOKAEK-2025/04/09 Project No: 2025/72). The research was conducted in accordance with the principles of the Declaration of Helsinki.

Supporting Institution

There is no supporting/funding institution.

References

• Familiari P, Mangiola F, Parmigiani M, Landi R. POEM for non-achalasia spastic oesophageal motility disorders. Best Pract Res Clin Gastroenterol. 2024;71:101909. doi:10.1016/j.bpg.2024.101909
• Bobircă F, Doran H, Dumitrescu D, et al. Achalasia at the crossroads between specialties. Chirurgia (Bucur). 2022;117(1):14-21. doi:10.21614/chirurgia.2683
• Dhawan I, O'Connell B, Patel A, Schey R, Parkman HP, Friedenberg F. Utility of esophageal high-resolution manometry in clinical practice: first, do HRM. Dig Dis Sci. 2018;63(12):3178-3186. doi:10.1007/s10620-018-5300-4
• Yadlapati R, Pandolfino JE, Fox MR, Bredenoord AJ, Kahrilas PJ. What is new in Chicago Classification version 4.0? Neurogastroenterol Motil. 2021;33(1):e14053. doi:10.1111/nmo.14053
• Savarino EV, Salvador R, Ghisa M, et al. Research gap in esophageal achalasia: a narrative review. Dis Esophagus. 2024;37(8):doae024. doi:10. 1093/dote/doae024
• Taft TH, Carlson DA, Triggs J, et al. Evaluating the reliability and construct validity of the Eckardt symptom score as a measure of achalasia severity. Neurogastroenterol Motil. 2018;30(6):e13287. doi:10. 1111/nmo.13287
• Fox MR, Sweis R, Yadlapati R, et al. Chicago classification version 4.0© technical review: uUpdate on standard high-resolution manometry protocol for the assessment of esophageal motility. Neurogastroenterol Motil. 2021;33(4):e14120. doi:10.1111/nmo.14120
• World Health Organization. Ageing and health. Updated October 1, 2024. Accessed June 7, 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health
• Mikaeli J, Islami F, Malekzadeh R. Achalasia: a review of Western and Iranian experiences. World J Gastroenterol. 2009;15(40):5000-5009. doi: 10.3748/wjg.15.5000
• Zhou MJ, Kamal A, Freedberg DE, Markowitz D, Clarke JO, Jodorkovsky D. Type II achalasia is increasing in prevalence. Dig Dis Sci. 2021;66(10):3490-3494. doi:10.1007/s10620-020-06668-7
• Abbas S, Akhtar TS, Chinnam S, et al. Optimizing achalasia diagnosis in the era of high-resolution manometry: a Pakistani perspective. JGH Open. 2025;9(3):e70041. doi:10.1002/jgh3.70041
• Salvador R, Costantini M, Tolone S, et al. Manometric pattern progression in esophageal achalasia in the era of high-resolution manometry. Ann Transl Med. 2021;9(10):906. doi:10.21037/atm.2020.03.149
• Pratap N, Kalapala R, Darisetty S, et al. Achalasia cardia subtyping by high-resolution manometry predicts the therapeutic outcome of pneumatic balloon dilatation. J Neurogastroenterol Motil. 2011;17(1):48-53. doi:10.5056/jnm.2011.17.1.48
• Şirin G, Konduk BT, Şirin S, Çelebi A. High resolution manometry for diagnosis of achalasia: tertiary reference center experience. Endoskopi Gastrointestinal. 2019;27(3):74-79. doi:10.17940/endoskopi.679107
• Rehman H, Abid A, Awan S, Hashmi FL, Abid S. Spectrum and clinical outcome of motility disorders on high-resolution esophageal manometry: a study from a tertiary center on patients with dysphagia in Pakistan. Cureus. 2020;12(12):e12088. doi:10.7759/cureus.12088
• Kahrilas PJ, Boeckxstaens G. The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometry. Gastroenterology. 2013;145(5):954-965. doi:10.1053/j.gastro.2013.08.038
• Lee K, Hong SP, Yoo IK, et al. Global trends in incidence and prevalence of achalasia, 1925-2021: a systematic review and meta-analysis. United European Gastroenterol J. 2024;12(4):504-515. doi:10.1002/ueg2.12555
• Kim GH, Park H, Jung KW, et al. Incidence, morbidity, and mortality of achalasia: a nationwide, population-based cohort study in South Korea. Gut Liver. 2023;17(6):894-904. doi:10.5009/gnl220334
• Patel DA, Yadlapati R, Vaezi MF. Esophageal motility disorders: current approach to diagnostics and therapeutics. Gastroenterology. 2022;162(6): 1617-1634. doi:10.1053/j.gastro.2021.12.289
• Patti MG, Herbella FA. Laparoscopic heller myotomy versus peroral endoscopic myotomy for the treatment of achalasia. Curr Opin Gastroenterol. 2024;40(4):314-318. doi:10.1097/MOG.0000000000001024
• Pesce M, Pagliaro M, Sarnelli G, Sweis R. Modern achalasia: diagnosis, classification, and treatment. J Neurogastroenterol Motil. 2023;29(4):419-427. doi:10.5056/jnm23125
• Pasta A, Calabrese F, Ghezzi A, et al. Diagnostic delay in achalasia. Dig Liver Dis. 2024;56(11):1839-1844. doi:10.1016/j.dld.2024.05.001
• Atalay S, Akçakaya A. Comparison of laparoscopic Heller myotomy and endoscopic balloon dilation in the treatment of achalasia: effects on quality of life and patient satisfaction. Ulus Travma Acil Cerrahi Derg. 2024;30(11):775-779. doi:10.14744/tjtes.2024.27030
• Schneider AM, Louie BE, Warren HF, Farivar AS, Schembre DB, Aye RW. A matched comparison of per oral endoscopic myotomy to laparoscopic Heller myotomy in the treatment of achalasia. J Gastrointest Surg. 2016; 20(11):1789-96. doi:10.1007/s11605-016-3232-x
• Wang HM, Tai WC, Chuah SK, et al. Comparison of treatment outcomes of endoscope-guided pneumatic dilation and laparoscopic Heller myotomy. Kaohsiung J Med Sci. 2015;31(12):639-643. doi:10.1016/j.kjms. 2015.10.003
• Aiolfi A, Bona D, riva cg, et al. systematic review and bayesian network meta-analysis comparing laparoscopic Heller myotomy, pneumatic dilatation, and peroral endoscopic myotomy for esophageal achalasia. J Laparoendosc Adv Surg Tech A. 2020;30(2):147-155. doi:10.1089/lap. 2019.0432